Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 1 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

0
Player Avatar pchop123 (79.45) Submitted: 9/11/2013 10:19:47 PM : Underperform Start Price: $2.61 ENZ Score: +6.68

wwhere is the beef (profits)?

Featured Broker Partners


Advertisement